title: Altered Na(+)-K+ ATPase activity in uraemic adolescents.
abstract: The Na(+)-K+ ATPase enzyme plays an essential role in the regulation of cell composition and volume. Enzyme activity itself is regulated by substrate availability and several hormones. In adult uraemic patients red blood cell Na(+)-K+ ATPase activity is decreased. However, it is unknown if children with uraemia exhibit the same phenomenon. Therefore, in the present study we examined whether endogenous digoxin-like factors (EDLF) and physicochemical membrane properties play a role in the regulation of erythrocyte Na(+)-K+ ATPase activity in uraemic children and adolescents. Healthy age-matched children were used as controls. Enzyme activity was measured in detergent-pretreated red blood cells and erythrocyte ghosts. Na(+)-K+ ATPase activity (2204 +/- 538 nmol Pi ml erythrocyte-1 h-1 in detergent pretreated erythrocytes; 204 +/- 56 nmol Pi mg protein-1 h-1 in ghosts) in adolescents with uraemia was lower compared to controls (3245 +/- 362 nmol Pi ml erythrocyte-1 h-1; 266 +/- 37 nmol Pi mg protein-1 h-1, p < 0.001, p < 0.05, respectively). Plasma levels of EDLF were elevated in uraemic patients (0.30 +/- 0.05 versus 0.21 +/- 0.04 ng ml-1, p < 0.01). Furthermore, the membrane lipid component was decreased in patients with uraemia, while the cholesterol/phospholipid ratio and membrane fluidity were similar in both groups. No correlation was found between the decrease in Na(+)-K+ ATPase and the increase in EDLF concentration and altered membrane lipid components. Our results demonstrate, that similar to the findings of adults, the activity of Na(+)-K+ ATPase is diminished in uraemic adolescent patients, and that uraemia-associated elevation in EDLF and altered membrane components do not play a role in the down-regulation of Na(+)-K+ ATPase. Therefore other factors (presence of other inhibitors and/or reduced number of enzyme molecules) should contribute to the lower activity of the Na(+)-K+ pump.
authors.affiliation: First Department of Paediatrics, Semmelweis Medical School, Budapest, Hungary.
authors.forename: B
authors.initials: B
authors.lastname: Vásárhelyi
authors.forename: P
authors.initials: P
authors.lastname: Sallay
authors.forename: E
authors.initials: E
authors.lastname: Balog
authors.forename: G
authors.initials: G
authors.lastname: Reusz
authors.forename: T
authors.initials: T
authors.lastname: Tulassay
mesh_terms: D000293:Adolescent; D000328:Adult; D002298:Cardenolides; D002784:Cholesterol / Q000097:blood; D004077:Digoxin; D015536:Down-Regulation; D004791:Enzyme Inhibitors / Q000097:blood*; D004910:Erythrocyte Membrane / Q000201:enzymology*; D005260:Female; D005454:Fluorescence Polarization; D006801:Humans; D008297:Male; D008563:Membrane Lipids / Q000097:blood; D010743:Phospholipids / Q000097:blood; D012503:Saponins / Q000097:blood*; D000254:Sodium-Potassium-Exchanging ATPase / Q000037:antagonists & inhibitors / Q000097:blood*; D014511:Uremia / Q000201:enzymology*
chemical_list: D002298:Cardenolides; D004791:Enzyme Inhibitors; D008563:Membrane Lipids; D010743:Phospholipids; D012503:Saponins; C034504:digoxin-like factors; D004077:Digoxin; D002784:Cholesterol; D000254:Sodium-Potassium-Exchanging ATPase